Vaccines broader value advisory board

On the 11th of November Pfizer organized an advisory board on the broader value of vaccines. Experts of the field were invited to provide feedback on the broader benefits of vaccines and how to apply to HTA assessment to ensure full value of vaccines has been captured.

During the meeting, the different frameworks available and the usefulness of these frameworks for decision making were also discussed. Inge van der Putten was invited to give her expert opinion based on her findings on the PhD thesis: Using information on the broader economic impact of vaccines in evidence-informed decision making. 

Also read

  • The DRIVE-RM consortium, including UM-professor Clemens van Blitterswijk and his team, has been awarded €37.5 million under the prestigious NWO SUMMIT program. The SUMMIT grant recognizes world-class collaborations, while further strengthening these partnerships.

  • Considering the master’s programme Epidemiology at Maastricht University? As a student, you’ll join a broad one-year programme that continuously strives for improvement. After graduation you’ll be eligible to become certified as an Epidemiologist A, and after obtaining a PhD in epidemiology at the...

  • The Honours programme is an extracurricular activity for bachelor’s students in year 2 and 3 to showcase their academic skills and teamwork in a real-life project. We talked to Emma van Straten, a Health Sciences student and Honours alumna who organised an international conference on Lama2 in...